Laura Corneillie

Mrs. Laura Corneillie


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2023 in Journal of Hepatology
Verified
Journal Article
Open access
OCOmbretta Colasanti
Ombretta Colasanti
RBRani Burm
Rani Burm
HHHao-En Huang
Hao-En Huang
TRTobias Riedl
Tobias Riedl
JTJannik Traut
Jannik Traut
Volker LohmannVolker Lohmann
Volker Lohmann
Hepatitis A virus (HAV) infections are considered not to trigger innate immunity in vivo, in contrast to hepatitis C virus (HCV). This lack of induction has been imputed to strong interference by HAV proteases 3CD and 3ABC. We aimed at elucidating the mechanisms of immune activation and counteraction by HAV and HCV in vivo and in vitro. UPA-SCID mice with humanized liver were infected with HAV and HCV. Hepatic cell culture models were used to assess HAV and HCV sensing by TLR3 and RIG-I/MDA5, respectively. Cleavage of the adaptor proteins TRIF and MAVS was analysed by transient and stable expression of HAV and HCV proteases and virus infection. We detected similar levels of Interferon stimulated genes (ISGs) induction in hepatocytes of HAV and HCV infected mice with humanized liver. In cell culture, HAV induced ISGs exclusively upon MDA5 sensing and depended on LGP2. TRIF and MAVS were only partially cleaved by HAV 3ABC and 3CD, not sufficiently to abrogate signalling. In contrast, HCV NS3-4 A efficiently degraded MAVS, as previously reported, whereas TRIF cleavage was not detected. HAV induces an innate immune response in hepatocytes via MDA5/LGP2, with limited control of both pathways by proteolytic cleavage. HCV activates TLR3 and lacks TRIF cleavage, suggesting that this pathway mainly contributes to HCV induced antiviral response in hepatocytes. Our results shed new light on induction and counteraction of innate immunity by HAV and HCV.

18 June 2019 in Viruses
Verified
Journal Article
Open access
PDF file
LCLaura Corneillie
Laura Corneillie
DBDominic H. Banda
Dominic H. Banda
PMPhilip Meuleman
Philip Meuleman
Hepatitis E virus (HEV) is an underdiagnosed pathogen with approximately 20 million infections each year and currently the most common cause of acute viral hepatitis. HEV was long considered to be confined to developing countries but there is increasing evidence that it is also a medical problem in the Western world. HEV that infects humans belongs to the Orthohepevirus A species of the Hepeviridae family. Novel HEV-like viruses have been observed in a variety of animals and some have been shown to be able to cross the species barrier, causing infection in humans. Several cell culture models for HEV have been established in the past years, but their efficiency is usually relatively low. With the circulation of this virus and related viruses in a variety of species, several different animal models have been developed. In this review, we give an overview of these animal models, indicate their main characteristics, and highlight how they may contribute to our understanding of the basic aspects of the viral life cycle and cross-species infection, the study of pathogenesis, and the evaluation of novel preventative and therapeutic strategies.

13 October 2023 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
LCLaura Corneillie
Laura Corneillie
ILIrma Lemmens
Irma Lemmens
CMClaire Montpellier
Claire Montpellier
MFMartin Ferrié
Martin Ferrié
KWKarin Weening
Karin Weening
PMPhilip Meuleman
Philip Meuleman

12 December 2023 in Viruses
Verified
Journal Article
Open access
PDF file
LCLaura Corneillie
Laura Corneillie
ILIrma Lemmens
Irma Lemmens
KWKarin Weening
Karin Weening
AMAmse De Meyer
Amse De Meyer
FHFreya Van Houtte
Freya Van Houtte
PMPhilip Meuleman
Philip Meuleman
Throughout their life cycle, viruses interact with cellular host factors, thereby influencing propagation, host range, cell tropism and pathogenesis. The hepatitis E virus (HEV) is an underestimated RNA virus in which knowledge of the virus–host interaction network to date is limited. Here, two related high-throughput mammalian two-hybrid approaches (MAPPIT and KISS) were used to screen for HEV-interacting host proteins. Promising hits were examined on protein function, involved pathway(s), and their relation to other viruses. We identified 37 ORF2 hits, 187 for ORF3 and 91 for ORF4. Several hits had functions in the life cycle of distinct viruses. We focused on SHARPIN and RNF5 as candidate hits for ORF3, as they are involved in the RLR-MAVS pathway and interferon (IFN) induction during viral infections. Knocking out (KO) SHARPIN and RNF5 resulted in a different IFN response upon ORF3 transfection, compared to wild-type cells. Moreover, infection was increased in SHARPIN KO cells and decreased in RNF5 KO cells. In conclusion, MAPPIT and KISS are valuable tools to study virus–host interactions, providing insights into the poorly understood HEV life cycle. We further provide evidence for two identified hits as new host factors in the HEV life cycle.